Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
Outlook Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(3) | Fee Rate | Amount of Registration Fee | |
| Fees to Be Paid | Equity | Common stock, par value $0.01 per share | Rule 457(c) | 515,755 (2) | $1.63 | $840,680.65 | 0.0001102 | $92.64 |
| Total Offering Amounts | $840,680.65 | $92.64 | ||||||
| Total Fees Previously Paid | — | |||||||
| Total Fee Offsets | — | |||||||
| Net Fee Due | $92.64 | |||||||
| (1) | Represents the shares of common stock, $0.01 par value per share (the “Common Stock”), of Outlook Therapeutics, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to the registration statement to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional shares of common stock as may be issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder. |
| (2) | Consists of an aggregate of 515,755 shares of the Registrant’s Common Stock issuable upon the exercise of placement agent warrants. |
| (3) | This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrant’s common stock on August 8, 2023, as reported on The Nasdaq Capital Market. |
